Tyra Grove Krause
Overview
Explore the profile of Tyra Grove Krause including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
77
Citations
1427
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Askar M, Ali K, Batke M, Brugger T, Falman A, Robertson A, et al.
Rev Med Virol
. 2025 Feb;
35(2):e70020.
PMID: 39994168
We performed an update (last search: 24 July 2023) of a systematic review on relative efficacy/effectiveness (rVE) and safety of newer/enhanced seasonal influenza vaccines in comparison with standard influenza vaccine...
2.
Hojbjerg Lassen M, Johansen N, Vaduganathan M, Bhatt A, Modin D, Chatur S, et al.
JACC Adv
. 2024 Nov;
3(12):101391.
PMID: 39606218
Background: Despite evidence demonstrating that influenza vaccination is associated with reduced risk of cardiovascular events and all-cause mortality in individuals with diabetes mellitus (DM), vaccine uptake remains suboptimal. Objectives: The...
3.
Madsen A, Gehrt L, Schaltz-Buchholzer F, Moller S, Christiansen R, Schellerup L, et al.
J Infect
. 2024 Oct;
89(6):106319.
PMID: 39423874
Objectives: The Bacillus Calmette-Guérin (BCG) vaccine may induce non-specific protection against unrelated infections. We tested the effect of BCG on the risk of infections among Danish senior citizens. Methods: Single-blinded...
4.
Johansen N, Vaduganathan M, Bhatt A, Modin D, Chatur S, Claggett B, et al.
JAMA
. 2024 Oct;
332(22):1900-1911.
PMID: 39392741
Importance: Despite strong worldwide guideline recommendations, influenza vaccination rates remain suboptimal among young and middle-aged patients with chronic diseases. Effective scalable strategies to increase vaccination are needed. Objective: To investigate...
5.
Johansen N, Vaduganathan M, Bhatt A, Modin D, Chatur S, Claggett B, et al.
Nat Med
. 2024 Aug;
30(11):3142-3149.
PMID: 39215149
Digital letter interventions have proven effective in increasing influenza vaccination rates. In this trial, we sought to further refine these strategies and investigated whether the effectiveness of the strategies could...
6.
Mesle M, Brown J, Mook P, Katz M, Hagan J, Pastore R, et al.
Lancet Respir Med
. 2024 Aug;
12(9):714-727.
PMID: 39127051
Background: By March, 2023, 54 countries, areas, and territories (hereafter CAT) in the WHO European Region had reported more than 2·2 million COVID-19-related deaths to the WHO Regional Office for...
7.
Obel N, Fox M, Tetens M, Pedersen L, Krause T, Ullum H, et al.
Clin Epidemiol
. 2024 Jul;
16:501-512.
PMID: 39081306
Background: Observational studies of SARS-CoV-2 vaccine effectiveness are prone to confounding, which can be illustrated using negative control methods. Methods: Nationwide population-based cohort study including two cohorts of Danish residents...
8.
Hojbjerg Lassen M, Johansen N, Modin D, Nealon J, Samson S, Dufournet M, et al.
Diabetes Obes Metab
. 2024 Apr;
26(5):1821-1829.
PMID: 38586966
Aim: High-dose quadrivalent influenza vaccine (QIV-HD) has been shown to be more effective than standard-dose (QIV-SD) in reducing influenza infection, but whether diabetes status affects relative vaccine effectiveness (rVE) is...
9.
Johansen N, Vaduganathan M, Bhatt A, Lee S, Modin D, Claggett B, et al.
Ann Intern Med
. 2024 Mar;
177(4):476-483.
PMID: 38498876
Background: In the NUDGE-FLU (Nationwide Utilization of Danish Government Electronic letter system for increasing inFLUenza vaccine uptake) trial, electronic letters incorporating cardiovascular (CV) gain-framing and repeated messaging increased influenza vaccination...
10.
Johansen N, Vaduganathan M, Bhatt A, Modin D, Chatur S, Claggett B, et al.
Am Heart J
. 2024 Mar;
272:23-36.
PMID: 38460754
Background: Yearly influenza vaccination is strongly recommended for older adults and patients with chronic diseases including cardiovascular disease (CVD); however, vaccination rates remain suboptimal, particularly among younger patients. Electronic letters...